Abstracts (HTML) List of Authors

Pachofszky, T

Endosonographisch gezielte Radiofrequenzablation zur Behandlung benigner Insulinome

Pai, RK

ASSOCIATION BETWEEN HISTOLOGICAL INDICES AND ULCERATIVE COLITIS ACTIVITY MEASURES AMONG PATIENTS IN THE HICKORY (ETROLIZUMAB) OPEN-LABEL INDUCTION (OLI) COHORT

Painsipp, J

DAA therapy for chronic hepatitis c infection: risk factors for nonadherence and relapse

Panaccione, R

Efficacy of Ustekinumab for Ulcerative Colitis Through 2 Years: Results of the UNIFI Maintenance Study and Long-term Extension

Panés, J

Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trial

Panzer, M

Neurodegenerative patterns in Wilson disease with hepatic or neurological manifestation assessed by morphometric magnetic resonance imaging

Papay, P

The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease

Paternostro, R

Inflammation promotes liver fibrogenesis in humans with advanced chronic liver disease
Use of human albumin in a large “real-life” single-center cohort of patients with decompensated advanced chronic liver disease
Incidence and outcome of acute-on-chronic liver failure in a large retrospective single-center cohort
Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease
Humoral biomarkers of hemodynamic derangement in distinct stages of portal hypertension
Beta blocker therapy seems to reduce systemic inflammation in cirrhotic patients with portal hypertension - a paired HVPG study
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy

Paulweber, B

The natural course of anti-mitochondrial antibody positive subjects is similar in confirmatory immunoblot-M2 positive and negative subjects

Paumgartner, G

Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through modulating the inflammatory signaling

Peck-Radosavljevic, M

Elevation of liver enzyme under immunotherapy with checkpoint inhibitors
Challenges in hepatitis C elimination despite highly effective antiviral agents - experience of a tertiary Hepatology center
Endoscopic ultrasound (EUS) in elderly patients
Usefullness of Endoscopic Ultrasound (EUS) in early biliary pancreatitis without cholestasis on conventional imaging
Factors associated with the presence of cirrhotic cardiomyopathy defined according to the new Multidisciplinary Diagnostic Criteria
Comparison between accuracy of flexible nitinol fine needle aspiration(FNA) and fine needle biopsy(FNB) endoscopic ultrasound (EUS) needles for solid pancreatic masses-retrospective bicentric analysis
Real-Life Perceptions on the Use of Albumin in Patients with Liver Cirrhosis in Specialized Gastroenterology Units in Austria
Bleeding risk after endosonographic (EUS) puncture of pancreas masses- comparison between aspiration (FNA) and biopsy (FNB) fine needles
Incidence of sedation-related complications and risk factors associated with non-anesthesiologist administration of sedation in endoscopic ultrasound (EUS)- prospective study
RGB Image analysis of pancreatic mass-elastographies in endoscopic ultrasound (EUS) can predict malignancy- a pilot study
Real-Life Perceptions on the management and prevention of variceal bleeding in Specialized Gastroenterology Units in Austria

Pencek, R

Durable Response in the Markers of Cholestasis Through 5 Years of Open-Label Extension Study of Obeticholic Acid in Primary Biliary Cholangitis

Penz, D

Impact of lesion phenotype on colorectal cancer mortality and overall mortality: insights from a nationwide screening colonoscopy program

Peters, P

The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease
Duale Biologikatherapie bei CED - eine weitere Option?

Peyrin-Biroulet, L

Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trial
ASSOCIATION BETWEEN HISTOLOGICAL INDICES AND ULCERATIVE COLITIS ACTIVITY MEASURES AMONG PATIENTS IN THE HICKORY (ETROLIZUMAB) OPEN-LABEL INDUCTION (OLI) COHORT
ETROLIZUMAB IMPROVED ENDOSCOPIC SCORE, PATIENT REPORTED OUTCOMES, AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH MODERATE TO SEVERE UC WHO HAD FAILED TNF ANTAGONIST THERAPY: THE HICKORY OPEN-LABEL INDUCTION (OLI) COHORT
Efficacy of Ustekinumab for Ulcerative Colitis Through 2 Years: Results of the UNIFI Maintenance Study and Long-term Extension
Corticosteroid Sparing Effects of Ustekinumab Therapy for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension

Pfeifer, B

Penetrance, cancer incidence and survival of hemochromatosis in a long-term follow-up and epidemiological modeling study

Pfister, A

Selektive Effekte des JAK-Inhibitors Tofacitinib auf die T-Zell Immunität
Der NAD+ salvage pathway in NK-Zellen bei intestinaler Inflammation

Pfisterer, N

Real-Life Perceptions on the Use of Albumin in Patients with Liver Cirrhosis in Specialized Gastroenterology Units in Austria
Real-Life Perceptions on the management and prevention of variceal bleeding in Specialized Gastroenterology Units in Austria

Pichler, G

Dysbiosis in dementia is associated with gut barrier dysfunction and linked to malnutrition and prescription drug use

Pinte, Mr

Vitamin A deficiency is associated with disease severity and portal hypertension in patients with advanced chronic liver disease

Pinter, M

The impact of novel systemic treatment options on the outcome of patients with hepatocellular carcinoma
Predictors of response to immunotherapy in patients with hepatocellular carcinoma - a retrospective single-center experience
Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2)
Regorafenib dosing in patients with advanced hepatocellular carcinoma (HCC) - a retrospective real-world experience
Inflammation promotes liver fibrogenesis in humans with advanced chronic liver disease
Impact of genetic variants on regression of portal hypertension and clinical outcomes in ACLD patients after SVR
Non-invasive risk stratification by VCTE and VITRO after HCV eradication
Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy

Piribauer, M

Duale Biologikatherapie bei CED - eine weitere Option?

Piringer, P

Diagnosespezifische Gesundheitsinformationen für Laien
Diagnosespezifische Handlungsempfehlungen für Hausärzte

Pirker, R

Achieving hepatitis C elimination in people who inject drugs - interim results of an innovative screen-and-treat program in Austria
Directly observed therapy for hepatitis C with sofosbuvir/velpatasvir alongside opioid substitution as an effective micro elimination strategy in PWIDs at high risk of non-adherence to antiviral therapy - real world data from Vienna, Austria

Platzer, R

The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease

Pollheimer, M

Ein seltener und lange Zeit unklarer Fall: IgG4 - assoziierte Ösophagitis

Pomej, K

The impact of novel systemic treatment options on the outcome of patients with hepatocellular carcinoma
Predictors of response to immunotherapy in patients with hepatocellular carcinoma - a retrospective single-center experience
Regorafenib dosing in patients with advanced hepatocellular carcinoma (HCC) - a retrospective real-world experience

Portugaller, RH

A novel score to predict mortality after transjugular intrahepatic portosystemic shunt in patients with renal insufficiency

Posch,

Fibroscan® probe selection for lean adults

Primas, C

The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease

Przysiecki, N

Selektive Effekte des JAK-Inhibitors Tofacitinib auf die T-Zell Immunität

Püspök, A

Endosonographisch gezielte Radiofrequenzablation zur Behandlung benigner Insulinome